Universal Health Services's results for Q3 2026 (quarter ended Sep 30, 2026) come from the company's own earnings release, filed with the SEC on 2026-10-27. Everything below is taken from that filing; quotes are copied exactly. Company outlooks are the company's own.
At a glance
| Item | Value |
|---|---|
| Revenue (GAAP) | $4,733 million (+5.3% vs a year earlier) |
| Diluted EPS (GAAP) | $5.22 |
| Adjusted per-share figure (company's non-GAAP measure; FFO/AFFO for REITs) | $5.22 |
| Full-year guidance | No outlook given |
Guidance
No updated financial outlook in the release.
Why this label: No guidance figures; the release only refers to its 2026 operating results forecast 'as previously disclosed on July 27, 2026' without restating or updating it.
From the release
Revenue: "Net revenues increased by 5.3% to $4.733 billion during the third quarter of 2026, as compared to $4.495 billion during the third quarter of 2025."
Earnings per share: "its reported net income attributable to UHS was $308.7 million, or $5.22 per diluted share, during the third quarter of 2026, as compared to $373.0 million, or $5.86 per diluted share, during the third quarter of 2025."
Key fact: Net revenues rose 5.3% to $4.733 billion; diluted EPS fell to $5.22 from $5.86.
Source
Universal Health Services earnings release (SEC filing), accession 0001193125-26-434414, filed 2026-10-27.
Part of the Q3 2026 Guidance Tracker. Educational only, not advice. Free weekly recap every Sunday: yieldterminalpro.com/newsletter.